Table 2c.
Clinical Characteristics of the PC Patient between Type O and Non-type O.
| Characteristic | Total (n=406) |
Type O (n=91, 22.4%) |
Non-type O (n=315, 77.6%) |
p value |
|---|---|---|---|---|
| M/F | 220/186 (54.2%) |
55/36 (60.4%) |
165/150 (52.4%) |
0.172 |
| Age | 71.0±10.5 | 72.9±9.2 | 71.5±10.2 | 0.244 |
| BMI (95%CI) |
21.1 (20.7-21.4) |
21.8 (21.1-22.5) |
20.9 (20.4-21.3) |
0.016 |
| CEA level (ng/mL) Median (range) |
4.4 (0.1-1452) |
4.8 (0.1-140) |
4.1 (0.6-1,452) |
0.46 |
| CA19-9 level (U/mL) Median (range) |
217.5 (-390,822) |
239 (-313,740) |
217 (-390,821) |
0.222 |
| Tumor size (cm) Median (range) |
3.0 (0-10.0) |
3.0 (0-10.0) |
3.0 (0-10.0) |
0.091 |
| LN Metastasis No/Yes |
246/153 | 61/28 | 185/125 | 0.126 |
| Distant Metastasis No/Yes |
264/142 | 65/26 | 199/116 | 0.141 |
| Resection+chemotherapy/ Chemotherapy/ Palliative care |
172/161/73 | 41/37/13 | 131/124/60 | 0.558 |
PC: pancreatic cancer, M/F: male/female, BMI: body mass index, CI: confidential interval, LN: lymph node, CEA: carcinoembryonic antigen, CA19-9: carbohydrate antigen 19-9